Dr. Y. Katherine Xu is an expert in the fields of biotechnology, financial analysis, equity research, investments, and corporate finance. She is currently a partner at Decheng Capital and has been with the firm since May 2019. Prior to this, Dr. Xu held senior positions with William Blair & Co., Wedbush Securities, Credit Suisse, Pacific Growth Equities, and Petkevich & Partners. Dr. Xu was recognized by the Financial Times/StarMine “World’s Top Analysts” listing, ranking No. 7 overall for stock-picking in the United States for 2010, and No. 2 for stock-picking in biotechnology for 2011; she received the No. 2 ranking in the Wall Street Journal's “Best on the Street” listing for biotechnology for 2011 as well.
Dr. Xu received her B.A. degree from Kalamazoo College in Michigan. She earned a Ph.D. in developmental biology and a Ph.D. minor in engineering-economic systems and operations research from Stanford University’s Schools of Medicine and Engineering, respectively. She has served on the Board of the 1990 Institute for over 18 years and is also on the board of The Overseas Young Chinese Forum.